The most common spinal stenosis surgery is called decompressive laminectomy
The bottom line Earlier GLP-1s were game-changers, but 10% to 15% of people don't lose weight on them
A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities behind the weight loss boom
In the closely watched trial, known as Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT), more than 17,000 people who were considered overweight or had obesity and who had cardiovascular disease but not diabetes took either semaglutide or a placebo for an average of nearly three years
Most patients find they eat less naturally without strict calorie counting
Li S, Zheng L, Zhang J, Liu X, Wu Z